Le Lézard
Classified in: Health
Subjects: RCL, PSF, CFG

Food Recall Warning - Abbott brand Calcilo XD Powder recalled due to rancidity and off-colour


Product photo is available: http://inspection.gc.ca/eng/1568425849063/1568425849551

OTTAWA, Sept. 13, 2019 /CNW/ - Abbott Laboratories is recalling Abbott brand Calcilo XD powder from the marketplace due to rancidity and off-colour.  Consumers should not consume the recalled product described below.

The following product has been sold in British Columbia, Alberta, Manitoba, Newfoundland, Nova Scotia, Ontario, Quebec and Saskatchewan. 

Recalled product

 

Brand

Product

Size

UPC

Codes

Abbott

Calcilo XD Powder

375 g

0 70074 53329 2

79696K80

 

What you should do

Check to see if you have the recalled product in your home. Recalled products should be thrown out or returned to the location where they were purchased.

Food that is rancid, has an unusual odour or smells 'off' should not be consumed. Consumption of rancid food may cause symptoms such as nausea, vomiting and diarrhea.

Background

This recall was triggered by the company. The Canadian Food Inspection Agency (CFIA) is conducting a food safety investigation, which may lead to the recall of other products. If other high-risk products are recalled, the CFIA will notify the public through updated Food Recall Warnings.

The CFIA is verifying that industry is removing the recalled product from the marketplace.

Illnesses

There have been reported illnesses associated with the consumption of this product.

SOURCE Canadian Food Inspection Agency (CFIA)


These press releases may also interest you

at 03:47
Zest Dental Solutions, a global leader in innovative dental solutions proudly announces a strategic partnership with The Pathway. Founded by Justin Moody, DDS and based in Arizona, The Pathway is a continuing education program that teaches dentists...

at 03:34
Medivir AB (STO: MVIR), a pharmaceutical company focused on developing innovative treatments for cancer in areas of high unmet medical need, announced today that its selective cathepsin K inhibitor, MIV-711, has been granted Rare Pediatric Disease...

at 03:16
First quarter Net sales reached SEK 9.4 (13.0) million.The operating result totaled SEK -18.4 (-14.4) million.Earnings per share, basic and diluted, were SEK -0.11 (-0.09).Cash flow from operating activities totaled SEK -7.3 (-12.2) million.CEO...

at 03:03
International medical imaging IT and cybersecurity company Sectra (STO: SECT B) will provide its platform for medical education, Sectra Education Portal, to four university colleges in Denmark. With the solution, they aim to elevate the educational...

at 03:00
Sentrycs, a leading innovator in adaptive counter-drone solutions, is proud to announce its inclusion in the prestigious UK National Protective Security Authority Catalogue of Security Equipment (NPSA CSE).  ...

at 02:22
Swedish Orphan Biovitrum AB (publ) (Sobi®) today announced its report for the first quarter 2024 First Quarter 2024 Total revenue increased 19 per cent, 20 per cent at constant exchange rates, (CER)1, to SEK 6,256 M (5,239)Haematology revenue...



News published on and distributed by: